KANN DIE PHARMAKO-DSA DER NIERE DIE INTRAOPERATIVE SCHNELLSCHNITT-DIAGNOSTIK ERSETZEN?

Translated title of the contribution: Can selective pharmaco-angiography of renal tumor replace the examination under surgery?

C. H. Will, D. Bach, H. Koop, P. Impekoven

Research output: Contribution to journalArticle

Abstract

Question: Can primary nephrectomy be performed without preliminary sample excision of the tumor if pharmaco-angiography of the kidney has demonstrated the typical tumor vascularization? Material and method: To clarify this question in 32 patients with 'displacing mass' of the kidney, verified in sonography and computer-tomography, or hematuria of unknown origin, we prospectively performed an additional pharmaco-angiography of the respective kidney. Results: In 18 patients with tumor vascularization in the pharmaco-angiography, intraoperatively we found 15 malignant renal cell carcinomas, 1 patient with transitional cell carcinoma of the renal pelvis, 1 leiomyosarcoma, and 1 high-differentiated tumor of only 2 cm in diameter with unclear dignity, which was treated by enucleation. Conclusion: In cases of an intrarenal lesion of more than 3 cm in diameter and additional tumor vascularization seen in selective pharmaco-angiography, the kidney undoubtedly can be removed by primary nephrectomy without a preliminary sample excision to confirm the diagnosis. For tumors with a diameter of less than 3 cm and additional tumor-vascularization, the option should be enucleation. If there is a 'tumor' without typical malignant vascularization, the exploration by sample excision should be performed. Depending on the histological result the tumor should be removed by enucleation or nephrectomy.

Original languageGerman
Pages (from-to)87-90
Number of pages4
JournalAktuelle Radiologie
Volume6
Issue number2
Publication statusPublished - 1996

Fingerprint

Angiography
Kidney
Neoplasms
Nephrectomy
Kidney Pelvis
Leiomyosarcoma
Transitional Cell Carcinoma
Hematuria
Ultrasonography
Tomography

Keywords

  • angiography
  • CT
  • pharmaco-angiography
  • renal tumour

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

KANN DIE PHARMAKO-DSA DER NIERE DIE INTRAOPERATIVE SCHNELLSCHNITT-DIAGNOSTIK ERSETZEN? / Will, C. H.; Bach, D.; Koop, H.; Impekoven, P.

In: Aktuelle Radiologie, Vol. 6, No. 2, 1996, p. 87-90.

Research output: Contribution to journalArticle

Will, C. H. ; Bach, D. ; Koop, H. ; Impekoven, P. / KANN DIE PHARMAKO-DSA DER NIERE DIE INTRAOPERATIVE SCHNELLSCHNITT-DIAGNOSTIK ERSETZEN?. In: Aktuelle Radiologie. 1996 ; Vol. 6, No. 2. pp. 87-90.
@article{f921cfae05a9438f89ffeea947054ed1,
title = "KANN DIE PHARMAKO-DSA DER NIERE DIE INTRAOPERATIVE SCHNELLSCHNITT-DIAGNOSTIK ERSETZEN?",
abstract = "Question: Can primary nephrectomy be performed without preliminary sample excision of the tumor if pharmaco-angiography of the kidney has demonstrated the typical tumor vascularization? Material and method: To clarify this question in 32 patients with 'displacing mass' of the kidney, verified in sonography and computer-tomography, or hematuria of unknown origin, we prospectively performed an additional pharmaco-angiography of the respective kidney. Results: In 18 patients with tumor vascularization in the pharmaco-angiography, intraoperatively we found 15 malignant renal cell carcinomas, 1 patient with transitional cell carcinoma of the renal pelvis, 1 leiomyosarcoma, and 1 high-differentiated tumor of only 2 cm in diameter with unclear dignity, which was treated by enucleation. Conclusion: In cases of an intrarenal lesion of more than 3 cm in diameter and additional tumor vascularization seen in selective pharmaco-angiography, the kidney undoubtedly can be removed by primary nephrectomy without a preliminary sample excision to confirm the diagnosis. For tumors with a diameter of less than 3 cm and additional tumor-vascularization, the option should be enucleation. If there is a 'tumor' without typical malignant vascularization, the exploration by sample excision should be performed. Depending on the histological result the tumor should be removed by enucleation or nephrectomy.",
keywords = "angiography, CT, pharmaco-angiography, renal tumour",
author = "Will, {C. H.} and D. Bach and H. Koop and P. Impekoven",
year = "1996",
language = "German",
volume = "6",
pages = "87--90",
journal = "Aktuelle Radiologie",
issn = "1433-5972",
publisher = "Georg Thieme Verlag",
number = "2",

}

TY - JOUR

T1 - KANN DIE PHARMAKO-DSA DER NIERE DIE INTRAOPERATIVE SCHNELLSCHNITT-DIAGNOSTIK ERSETZEN?

AU - Will, C. H.

AU - Bach, D.

AU - Koop, H.

AU - Impekoven, P.

PY - 1996

Y1 - 1996

N2 - Question: Can primary nephrectomy be performed without preliminary sample excision of the tumor if pharmaco-angiography of the kidney has demonstrated the typical tumor vascularization? Material and method: To clarify this question in 32 patients with 'displacing mass' of the kidney, verified in sonography and computer-tomography, or hematuria of unknown origin, we prospectively performed an additional pharmaco-angiography of the respective kidney. Results: In 18 patients with tumor vascularization in the pharmaco-angiography, intraoperatively we found 15 malignant renal cell carcinomas, 1 patient with transitional cell carcinoma of the renal pelvis, 1 leiomyosarcoma, and 1 high-differentiated tumor of only 2 cm in diameter with unclear dignity, which was treated by enucleation. Conclusion: In cases of an intrarenal lesion of more than 3 cm in diameter and additional tumor vascularization seen in selective pharmaco-angiography, the kidney undoubtedly can be removed by primary nephrectomy without a preliminary sample excision to confirm the diagnosis. For tumors with a diameter of less than 3 cm and additional tumor-vascularization, the option should be enucleation. If there is a 'tumor' without typical malignant vascularization, the exploration by sample excision should be performed. Depending on the histological result the tumor should be removed by enucleation or nephrectomy.

AB - Question: Can primary nephrectomy be performed without preliminary sample excision of the tumor if pharmaco-angiography of the kidney has demonstrated the typical tumor vascularization? Material and method: To clarify this question in 32 patients with 'displacing mass' of the kidney, verified in sonography and computer-tomography, or hematuria of unknown origin, we prospectively performed an additional pharmaco-angiography of the respective kidney. Results: In 18 patients with tumor vascularization in the pharmaco-angiography, intraoperatively we found 15 malignant renal cell carcinomas, 1 patient with transitional cell carcinoma of the renal pelvis, 1 leiomyosarcoma, and 1 high-differentiated tumor of only 2 cm in diameter with unclear dignity, which was treated by enucleation. Conclusion: In cases of an intrarenal lesion of more than 3 cm in diameter and additional tumor vascularization seen in selective pharmaco-angiography, the kidney undoubtedly can be removed by primary nephrectomy without a preliminary sample excision to confirm the diagnosis. For tumors with a diameter of less than 3 cm and additional tumor-vascularization, the option should be enucleation. If there is a 'tumor' without typical malignant vascularization, the exploration by sample excision should be performed. Depending on the histological result the tumor should be removed by enucleation or nephrectomy.

KW - angiography

KW - CT

KW - pharmaco-angiography

KW - renal tumour

UR - http://www.scopus.com/inward/record.url?scp=0029872854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029872854&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 87

EP - 90

JO - Aktuelle Radiologie

JF - Aktuelle Radiologie

SN - 1433-5972

IS - 2

ER -